M&As this Week: Capio, BioStem Technologies, Virtus Health

2nd March 2018 (Last Updated August 12th, 2019 10:39)

Capio AB (publ) has entered an agreement to acquire 100% interest in healthcare and dental care services provider Novakliniken. 

Capio AB (publ) has entered an agreement to acquire 100% interest in healthcare and dental care services provider Novakliniken.

The healthcare services company will have 28 primary care centres and 220,000 listed patients in Skane region, upon completion of the acquisition in April 2018.

Both companies involved in the acquisition are based in Sweden.

BioStem Technologies Inc has agreed to purchase Grupo Impulso De Incentivacion Para Nuevas Tecnologias (GIINT).

GIINT will become a wholly owned subsidiary of BioStem upon completion of the acquisition.

Based in Mexico, the acquiring company is a life sciences company involved in the development of pharmaceutical and regenerative medicine products.

"GIINT will become a wholly owned subsidiary of BioStem upon completion of the acquisition."

GIINT is based in Mexico and is a biotechnology company involved in stem cell research and development.

The acquisition will strengthen BioStem’s stem cell business.

Virtus Health Limited has signed an agreement to purchase 90% of Complete Fertility Limited (CFL) for £5m ($6.95m).

The business and assets related to fertility services provided by the University Hospital Southampton NHS Foundation Trust (UHS) are also part of the acquisition.

Virtus Health is an Australian healthcare services provider, while CFL is a fertility care provider based in the UK.

The transaction is expected to be closed by the end of this month.